EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hidradenitis suppurativa with and without draining tunnels: A real‐world study characterizing differences in treatment and disease burden

J R Ingram, A V Marzano iD, E Prens, S Schneider-Burrus iD, R B Warren, A Keal, R Jha, A C Hernandez Daly, A B Kimball

Journal of the European Academy of Dermatology and Venereology · 2025-08 · 39 (8) · 1431-1441

DOI: 10.1111/jdv.20550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 04.02.2025. Verfasst von J R Ingram und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection and Immunity, Cardiff University, University Hospital of Wales, Cardiff, UK. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Quality of Life, Cost of Illness. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hidradenitis suppurativa (HS) is a chronic, inflammatory, neutrophilic skin disease associated with a considerable clinical burden. In more severe disease, subepidermal draining tunnels may form.

Objectives

To characterize the clinical profile of patients with moderate–severe HS with and without draining tunnels, and the clinical and health‐related quality of life (HR‐QoL) burden of draining tunnels.

Methods

Data were drawn from the Adelphi HS Disease Specific Programme™, a cross‐sectional survey with retrospective data collection, across the United States, France, Germany, Italy, Spain and the United Kingdom between November 2020 and April 2021. Patients were aged ≥10 years and had HS. Clinical outcomes, recorded by physicians, comprised patient demographics and HS characteristics, symptoms and treatment. HR‐QoL measures included patient and physician survey questions, and validated HR‐QoL instruments.

Results

Of the 580 patients with moderate–severe HS, 46% had draining tunnels. Patients with draining tunnels had more abscesses, inflammatory nodules and scarring than those without. Patients with draining tunnels were significantly ( p < 0.05) more likely to be treated with biologics (41% vs. 27%), but often patients with tunnels who were eligible for biologics had not received them. Patients with draining tunnels experienced significantly more inflammation/redness (73% vs. 63%), drainage from lesions (62% vs. 40%) and pain on sitting (48% vs. 37%) than those without ( p < 0.05). Draining tunnels were also significantly associated with low mood/depression (30% vs. 18%), sleep disturbance (28% vs. 19%) and fatigue (28% vs. 18%) versus no tunnels ( p < 0.05). Physicians agreed that patients with draining tunnels experienced a negative impact of disease compared to those without. This was reflected in patient‐reported surveys and HR‐QoL instruments.

Conclusions

Patients with moderate–severe HS and draining tunnels experience greater clinical and HR‐QoL burden than those without, emphasizing the importance of tunnels in disease impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaQuality of LifeCost of IllnessHumansMaleFemaleCross-Sectional StudiesAdultMiddle AgedRetrospective StudiesSeverity of Illness IndexYoung AdultBiological Products

Substanzen

Biological Products

Autor:innen und Institutionen

  • Division of Infection and Immunity, Cardiff University, University Hospital of Wales, Cardiff, UK.
  • Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Center for Dermatosurgery, Berlin, Germany.
  • Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.

ORCID-Profile: A V Marzano, S Schneider-Burrus

Förderung

  • Boehringer Ingelheim

Zitieren

APA

Ingram, J. R., Marzano, A. V., Prens, E., Schneider-Burrus, S., Warren, R. B., Keal, A., Jha, R., Hernandez Daly, A. C., & Kimball, A. B. (2025). Hidradenitis suppurativa with and without draining tunnels: A real‐world study characterizing differences in treatment and disease burden. Journal of the European Academy of Dermatology and Venereology, 39(8), 1431-1441. https://doi.org/10.1111/jdv.20550

Vancouver

Ingram JR, Marzano AV, Prens E, Schneider-Burrus S, Warren RB, Keal A, et al. Hidradenitis suppurativa with and without draining tunnels: A real‐world study characterizing differences in treatment and disease burden. Journal of the European Academy of Dermatology and Venereology. 2025;39(8):1431-1441. doi:10.1111/jdv.20550

BibTeX
@article{Ingram2025,
  author = {Ingram, J R and Marzano, A V and Prens, E and Schneider-Burrus, S and Warren, R B and Keal, A and Jha, R and Hernandez Daly, A C and Kimball, A B},
  title = {Hidradenitis suppurativa with and without draining tunnels: A real‐world study characterizing differences in treatment and disease burden},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2025},
  volume = {39},
  number = {8},
  pages = {1431--1441},
  doi = {10.1111/jdv.20550}
}
Kostenlos starten →